Research Article

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia

Figure 4

The expression of OX40 and OX40L mRNA in PBMCs of patients. (a) The expression levels of OX40 mRNA in PBMCs from 10 ITP patients with positive antiplatelet autoantibodies, 12 ITP patients with negative antiplatelet autoantibodies, and 12 HCs. (b) The expression levels of OX40L mRNA in PBMCs from 10 ITP patients with positive antiplatelet autoantibodies, 12 ITP patients with negative antiplatelet autoantibodies, and 12 HCs. ITP(+): ITP patients with positive antiplatelet autoantibodies; ITP(-): ITP patients with negative antiplatelet autoantibodies. ; ; .
(a)
(b)